Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients.

导出 OA

翻译打印收藏纠错

作者： Natalia,Krawczyk ^[1] ; Bernadette,Jaeger ^[2] ; Piperek-Jäger,Martina ^[1] ; Lopez-Cotarelo Rodriguez-Noriega,Cristina ^[3] ; Neubacher,Melissa ^[1] ; Banys-Paluchowski,Maggie ^[4] ; Meier-Stiegen,Franziska ^[1] ; Neubauer,Hans ^[1] ; Niederacher,Dieter ^[1] ; Ruckhäberle,Eugen ^[1] ; Mohrmann,Svjetlana ^[1] ; Hoffmann,Jürgen ^[1] ; Kaleta,Thomas ^[1] ; Esposito,Irene ^[3] ; Fehm,Tanja ^[1]

作者单位： Department of Obstetrics and Gynaecology, University of Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany. ^[1] Department of Obstetrics and Gynaecology, University of Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany. bernadette.jaeger@med.uni-duesseldorf.de. ^[2] Department of Pathology, University of Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. ^[3] Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Lübeck, 23538, Lübeck, Germany. ^[4]

关键词 Minimal residual disease Predictive marker Targeted therapy

主题词人类(Humans);女(雌)性(Female);乳腺肿瘤(Breast Neoplasms);肿瘤细胞, 循环(Neoplastic Cells, Circulating);受体, 雄激素(Receptors, Androgen);预后(Prognosis)

DOI 10.1007/s00404-023-07225-z

PMID 37902839

发布时间 2024-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交